| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |